v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated other comprehensive loss
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 235,193 $ 62 $ 744,940 $ (136) $ (509,673)
Beginning balance, Shares at Dec. 31, 2023   61,915,367      
Issuance of common stock under employee benefit plans 2,746   2,746    
Issuance of common stock under employee benefit plans, Shares   530,610      
Vesting of restricted stock awards, Shares   22,326      
Issuance of pre-funded warrants in exchange for common stock, value   $ (9) 9    
Issuance of pre-funded warrants in exchange for common stock, Shares   (9,350,000)      
Issuance of common stock pursuant to pre-funded warrant exercise   $ 1 (1)    
Issuance of common stock pursuant to pre-funded warrant exercise shares   850,000      
Stock-based compensation expense 14,554   14,554    
Unrealized gain or loss on marketable securities 266     266  
Net Income (Loss) (9,725)       (9,725)
Ending balance at Dec. 31, 2024 243,034 $ 54 762,248 130 (519,398)
Ending balance, Shares at Dec. 31, 2024   53,968,303      
Vesting of restricted stock awards 0        
Vesting of restricted stock awards, Shares   11,003      
Stock-based compensation expense 3,167   3,167    
Unrealized gain or loss on marketable securities (60)     (60)  
Net Income (Loss) (17,655)       (17,655)
Ending balance at Mar. 31, 2025 228,486 $ 54 765,415 70 (537,053)
Ending balance, Shares at Mar. 31, 2025   53,979,306      
Beginning balance at Dec. 31, 2024 243,034 $ 54 762,248 130 (519,398)
Beginning balance, Shares at Dec. 31, 2024   53,968,303      
Unrealized gain or loss on marketable securities (48)        
Net Income (Loss) (34,951)        
Ending balance at Jun. 30, 2025 214,378 $ 54 768,591 82 (554,349)
Ending balance, Shares at Jun. 30, 2025   54,091,588      
Beginning balance at Dec. 31, 2024 243,034 $ 54 762,248 130 (519,398)
Beginning balance, Shares at Dec. 31, 2024   53,968,303      
Issuance of common stock, net of issuance costs 164,167 $ 12 164,155    
Issuance of common stock, Shares   11,851,853      
Issuance of common stock under employee benefit plans 4,167 $ 1 4,166    
Issuance of common stock under employee benefit plans, Shares   739,230      
Vesting of restricted stock awards, Shares   19,505      
Stock-based compensation expense 12,468   12,468    
Unrealized gain or loss on marketable securities 44     44  
Net Income (Loss) (74,880)       (74,880)
Ending balance at Dec. 31, 2025 349,000 $ 67 943,037 174 (594,278)
Ending balance, Shares at Dec. 31, 2025   66,578,891      
Beginning balance at Mar. 31, 2025 228,486 $ 54 765,415 70 (537,053)
Beginning balance, Shares at Mar. 31, 2025   53,979,306      
Issuance of common stock under employee benefit plans 301   301    
Issuance of common stock under employee benefit plans, Shares   103,780      
Vesting of restricted stock awards 0        
Vesting of restricted stock awards, Shares   8,502      
Stock-based compensation expense 2,875   2,875    
Unrealized gain or loss on marketable securities 12     12  
Net Income (Loss) (17,296)       (17,296)
Ending balance at Jun. 30, 2025 214,378 $ 54 768,591 82 (554,349)
Ending balance, Shares at Jun. 30, 2025   54,091,588      
Beginning balance at Dec. 31, 2025 349,000 $ 67 943,037 174 (594,278)
Beginning balance, Shares at Dec. 31, 2025   66,578,891      
Issuance of common stock under employee benefit plans 21   21    
Issuance of common stock under employee benefit plans, Shares   7,887      
Vesting of restricted stock awards 0        
Vesting of restricted stock awards, Shares   21,318      
Stock-based compensation expense 3,860   3,860    
Unrealized gain or loss on marketable securities (687)     (687)  
Net Income (Loss) (18,891)       (18,891)
Ending balance at Mar. 31, 2026 333,303 $ 67 946,918 (513) (613,169)
Ending balance, Shares at Mar. 31, 2026   66,608,096      
Beginning balance at Dec. 31, 2025 349,000 $ 67 943,037 174 (594,278)
Beginning balance, Shares at Dec. 31, 2025   66,578,891      
Unrealized gain or loss on marketable securities (741)        
Net Income (Loss) (45,070)        
Ending balance at Jun. 30, 2026 310,697 $ 76 950,536 (567) (639,348)
Ending balance, Shares at Jun. 30, 2026   76,285,157      
Beginning balance at Mar. 31, 2026 333,303 $ 67 946,918 (513) (613,169)
Beginning balance, Shares at Mar. 31, 2026   66,608,096      
Issuance of common stock under employee benefit plans 355   355    
Issuance of common stock under employee benefit plans, Shares   68,202      
Issuance of common stock pursuant to pre-funded warrant exercise 1 $ 9 (8)    
Issuance of common stock pursuant to pre-funded warrant exercise shares   9,608,859      
Stock-based compensation expense 3,271   3,271    
Unrealized gain or loss on marketable securities (54)     (54)  
Net Income (Loss) (26,179)       (26,179)
Ending balance at Jun. 30, 2026 $ 310,697 $ 76 $ 950,536 $ (567) $ (639,348)
Ending balance, Shares at Jun. 30, 2026   76,285,157